Paul Lizzul
Chief Tech/Sci/R&D Officer at ANAPTYSBIO, INC.
Net worth: 227 857 $ as of 30/03/2024
Profile
Paul F.
Lizzul is currently the Chief Medical Officer at AnaptysBio, Inc. and a Member of the American Academy of Dermatology.
He previously worked as the Executive Medical Director at Amgen, Inc., Senior Medical Director at Kythera Biopharmaceuticals LLC, Assistant Professor at Tufts University School of Medicine, and Chief Medical Officer at Sienna Biopharmaceuticals, Inc. Lizzul holds a doctorate from the University of Medicine & Dentistry of New Jersey, an undergraduate degree from Rensselaer Polytechnic Institute, a graduate degree from Robert Wood Johnson Medical School, and an MBA from Rutgers Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ANAPTYSBIO, INC.
0.04% | 07/01/2024 | 10,118 ( 0.04% ) | 227 857 $ | 30/03/2024 |
Paul Lizzul active positions
| Companies | Position | Start |
|---|---|---|
| ANAPTYSBIO, INC. | Chief Tech/Sci/R&D Officer | 30/07/2020 |
American Academy of Dermatology
 American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019. | Corporate Officer/Principal | - |
Former positions of Paul Lizzul
| Companies | Position | End |
|---|---|---|
| KYTHERA BIOPHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 31/12/2015 |
| Tufts University School of Medicine | Corporate Officer/Principal | 31/12/2011 |
| AMGEN INC. | Chief Tech/Sci/R&D Officer | - |
| SIENNA BIOPHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Paul Lizzul
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| Robert Wood Johnson Medical School | Graduate Degree |
| Rutgers Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| ANAPTYSBIO, INC. | Health Technology |
| SIENNA BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
American Academy of Dermatology
American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019. | Commercial Services |
- Stock Market
- Insiders
- Paul Lizzul
